Distinct signal transduction pathways mediate nuclear factor-kappaB induction by IL-1beta in epithelial and lymphoid cells
- PMID: 9548465
Distinct signal transduction pathways mediate nuclear factor-kappaB induction by IL-1beta in epithelial and lymphoid cells
Abstract
We previously demonstrated that IL-1beta-mediated induction of the nuclear factor-kappaB (NF-kappaB) transcription factor proceeds through the production of reactive oxygen intermediates in lymphoid cells, while it occurs independently of any oxidative stress in epithelial transformed cells. Indeed, inhibition of receptor internalization as well as NH4Cl and chloroquine blocked IL-1beta-mediated induction of NF-kappaB in OVCAR-3 and in other epithelial cell lines but not in lymphoid cells, indicating that distinct pathways are involved. Conversely, while we observed phospholipase A2 activity in both cell types following IL-1beta stimulation, specific inhibitors of this enzyme inhibited NF-kappaB induction only in lymphoid cells. Moreover, expression of the 5-lipoxygenase (5-LOX) enzyme was not detected in epithelial cells, and inhibition of this enzyme blocked NF-kappaB induction by IL-1beta only in lymphoid cells. This study thus indicates that the activation of NF-kappaB following IL-1beta treatment involves the activation of phospholipase A2 and 5-LOX and the production of reactive oxygen intermediates (ROIs) in lymphoid cells, while in epithelial cells, another pathway predominates and could involve the acid sphingomyelinase. Moreover, arachidonic acid could induce NF-kappaB in epithelial and lymphoid cells, but this activation involved the 5-LOX enzyme and the production of ROIs only in lymphoid cells. The inefficiency of the ROI pathway in epithelial cells is probably the consequence of both low ROI production due to undetectable expression of 5-LOX and rapid degradation of hydrogen peroxide due to high catalase activity.
Similar articles
-
Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity.Mol Cell Biol. 1999 Mar;19(3):1950-60. doi: 10.1128/MCB.19.3.1950. Mol Cell Biol. 1999. PMID: 10022882 Free PMC article.
-
Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1.Biochem Pharmacol. 2000 Jan 1;59(1):7-11. doi: 10.1016/s0006-2952(99)00290-7. Biochem Pharmacol. 2000. PMID: 10605929 Review.
-
Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1.J Immunol. 1998 Oct 1;161(7):3421-30. J Immunol. 1998. PMID: 9759860
-
Functional coupling between secretory and cytosolic phospholipase A2 modulates tumor necrosis factor-alpha- and interleukin-1beta-induced NF-kappa B activation.J Biol Chem. 2001 Aug 10;276(32):30527-36. doi: 10.1074/jbc.M008481200. Epub 2001 Jun 4. J Biol Chem. 2001. PMID: 11390371
-
The effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid.J Physiol Pharmacol. 2013 Aug;64(4):409-21. J Physiol Pharmacol. 2013. PMID: 24101387 Review.
Cited by
-
Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity.Mol Cell Biol. 1999 Mar;19(3):1950-60. doi: 10.1128/MCB.19.3.1950. Mol Cell Biol. 1999. PMID: 10022882 Free PMC article.
-
N-acetylcysteine in acute pancreatitis.World J Gastrointest Pharmacol Ther. 2010 Feb 6;1(1):21-6. doi: 10.4292/wjgpt.v1.i1.21. World J Gastrointest Pharmacol Ther. 2010. PMID: 21577291 Free PMC article.
-
A functional interplay between 5-lipoxygenase and μ-calpain affects survival and cytokine profile of human Jurkat T lymphocyte exposed to simulated microgravity.Biomed Res Int. 2014;2014:782390. doi: 10.1155/2014/782390. Epub 2014 Sep 16. Biomed Res Int. 2014. PMID: 25309925 Free PMC article.
-
Non-enzymatic triggering of the ceramide signalling cascade by solar UVA radiation.EMBO J. 2000 Nov 1;19(21):5793-800. doi: 10.1093/emboj/19.21.5793. EMBO J. 2000. PMID: 11060030 Free PMC article.
-
Thiocolchicoside exhibits anticancer effects through downregulation of NF-κB pathway and its regulated gene products linked to inflammation and cancer.Cancer Prev Res (Phila). 2010 Nov;3(11):1462-72. doi: 10.1158/1940-6207.CAPR-10-0037. Epub 2010 Oct 26. Cancer Prev Res (Phila). 2010. PMID: 20978115 Free PMC article.